Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

MicroMAX Collaborative Research Grants

Novo Nordisk

With the MicroMAX Collaborative Research Grants, the Novo Nordisk Foundation wishes to strengthen the user community at the MicroMAX beamline, which is located at the MAX IV Synchrotron in Lund, Sweden. MicroMAX is a macromolecular crystallography beamline optimised for serial-synchrotron crystallography with time-resolved capabilities, see MicroMAX – MAX IV for further details about the beamline. The goal of the programme is to:

Facilitate high-quality collaborative research projects at the MicroMAX beamline
Promote the MicroMAX beamline to a Danish user community while encouraging international collaboration
Establish expertise within serial synchrotron crystallography anchored at Danish non-profit research organisations
Educate and train early career researchers within advanced synchrotron crystallography methods that benefit the life science ecosystem
Advance the MicroMAX beamline’s capabilities, e.g. by the development of instrumentation and/or methods, that will benefit a large group of users

Deadline: Sep. 15, 2026

Specialties

Engineering and Physical Sciences

International Opportunities

Medical - Basic Science

Environmental & Life Sciences

Medical

Eligibility Requirements

The main applicant must be affiliated (at least 80% of a full-time position) with a Danish university, hospital or other non-profit organisation (host institution).

1 or 2 co-applicants are required for the application. The co-applicant(s) can be anchored in Denmark or abroad at a university, hospital or other non-profit research institution.

At least either the applicant or (one of) the co-applicant(s) must have expertise within synchrotron-based crystallography or closely related method(s).

Sponsor Details

Sponsor Institute/Organizations: Novo Nordisk

Sponsor Type:

Address: European Foundation for the Study of Diabetes ;Rheindorfer Weg 3; 40591 Düsseldorf ;Germany

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity